New York, October 15, 2026 / PRNewswire / -- Pomerantz LLP represents and is in charge of handling investor-related claims for Foghorn Therapeutics Inc ("Foghorn" or "the company") ( NASDAQ : FHTX ). The law firm advises concerned investors to contact Danielle Peyton, whose email address is [ email protected ] and phone number is 646-581-9980, extension 7980.

This investigation focuses on whether Foghorn and some of its senior executives and/or directors have engaged in securities fraud or other illegal business practices.

On October 1, 2026, Foghorn issued a press release stating, "After reviewing the clinical data from the first phase of the dose escalation trial of FHD-909 ( LY4050784 ), Foghorn and Lilly have decided not to proceed with this project into the clinical development expansion phase. The collaboration between the two parties will also not continue on the Selective SMARCA2 degrader project, and it is anticipated that no further cooperative activities will be carried out between the two companies. Therefore, Foghorn will now prioritize its resources towards projects within its own product portfolio that have the greatest potential to meet significant patient needs and create long-term value."

The press release also quoted the statement of Adrian Gottshalk, CEO of Foghorn, which said, " Foghorn will reduce its workforce by approximately 40% and further adjust its operational structure, so that the company's cash reserves will be sufficient to support the key projects of Foghorn until the second half of 2029."

Affected by this news, the stock price of Foghorn fell by $0.90 per share on October 2, 2026, a decrease of 30.82%, closing at $2.02 per share.

Pomerantz LLP has offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, and is considered one of the leading law firms in the fields of corporate, securities, and antitrust class actions. The firm was founded by the late Abraham L Pomerantz, who was known as the "dean" of the class action attorneys and pioneered the field of securities class actions. More than 85 years later, Pomerantz continues to carry on this tradition, fighting for the rights of victims of securities fraud, breach of fiduciary duty, and corporate misconduct. The firm states that it has secured millions of dollars in compensation for its class action members. For more details, please refer to www.pomlaw.com.

Lawyer advertisement. Past results do not guarantee similar outcomes in the future.

Contact Information: